Yiwu Spring Festival Gala Showed the World: More Than Just "Small Commodities"
YIWU, China, Feb. 25, 2026 /PRNewswire/ -- As the Yiwu branch venue of the 2026 CCTV Spring Festival Gala successfully concluded, an audio-visual feast blending trade legend with intangible cultural heritage innovation sparked enthusiastic reactions...
Thundercomm Brings On-Device AI Agents to Physical World From Smart Home to Action Cameras, to Robotics Based on AIOS platform
LAS VEGAS, Jan. 19, 2026 /PRNewswire/ -- Looking for a smart life solution, with just verbal communication via a 24/7 personal assistant that actually understands your need even that requires multi-step, even and cross-domain actions? In need for a...
ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...
Strava Releases 12th Annual Year in Sport Trend Report, Revealing That Doomscrolling Is Out, Movement Is In
New global data shows how Gen Z is prioritising fitness, connection, and community—plus unveils the year's top gear and new global city leaderboards. SAN FRANCISCO, Dec. 3, 2025 /PRNewswire/ -- Strava, the app for active people with over 180 million...
Visa Data Shows Affluent Leading Post-Race Tourism and Spending after the Singapore Grand Prix
One in five[1] travellers visiting Singapore continued their journey after the Grand Prix to top destinations including Indonesia, Malaysia, Thailand, Australia and Japan SINGAPORE, Oct. 31, 2025 /PRNewswire/ -- Visa, the world leader in digital...
Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO
CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3...
e-STORAGE's SolBank 3.0 Successfully Passes Large-Scale Fire Testing (LSFT)
KITCHENER, ON, June 3, 2025 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that e-STORAGE, which is part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. ("CSI Solar"), has...
Science and Technology Daily: Into Tech Park: Zooming In on China's Innovative Spirit
TIANJIN, China, May 20, 2025 /PRNewswire/ -- Imagine controlling objects with your mind, like a Marvel Comic superhero. In Tianjin, this fantasy is becoming reality. Picture Osuagwu Obinna Ikechukwu, a young Nigerian researcher at the University of...
Dizal's Golidocitinib in Combination with Anti-PD-1 Shows Promise in IO Resistant Non-Small Cell Lung Cancer
Golidocitinib is a JAK1 only inhibitor approved for the treatment of relapsed or refractory PTCL The combination of golidocitinib and PD-1 antibody showed synergistic anti-tumor effects in anti-PD-1-resistant NSCLC SHANGHAI, March 20, 2025...
Agoda Survey Reveals: Strong Interest in Family Travel and New Destinations Among South Korean Women
SEOUL, South Korea, March 11, 2025 /PRNewswire/ -- To mark International Women's Day which took place on March 8, digital travel platform Agoda unveiled travel insights about South Korean women. The findings revealed that while both men and women...